Experiences of progestin-only pill users in the United States and attitudes toward over-the-counter access.

IF 3.4 2区医学 Q1 DEMOGRAPHY

Perspectives on Sexual and Reproductive Health Pub Date : 2023-06-01 Epub Date: 2023-04-11 DOI:10.1363/psrh.12223

Carmela Zuniga, Hannah Forsberg, Kate Grindlay

{"title":"Experiences of progestin-only pill users in the United States and attitudes toward over-the-counter access.","authors":"Carmela Zuniga, Hannah Forsberg, Kate Grindlay","doi":"10.1363/psrh.12223","DOIUrl":null,"url":null,"abstract":"Context: Removing the prescription requirement and making oral contraceptive pills available over the counter (OTC) could increase contraceptive access in the United States. Despite current efforts to make a progestin-only pill (POP) available OTC, there are no qualitative data exploring the experiences of POP users and their perspectives on making POPs available OTC.Methods: We conducted six online, asynchronous focus group discussions with 36 POP users between July and November 2020. We stratified focus group discussion placement based on three reasons for POP use: breastfeeding, having a contraindication to estrogen (for a reason other than breastfeeding), and for any other reason. We thematically analyzed these data using inductive and deductive coding.Results: The majority of participants described their overall POP experience as positive, mostly because they experienced minor or no side effects and thought the pill was effective. Participants overwhelmingly supported OTC availability of POPs and expressed interest in purchasing an OTC POP. Over one-third of participants had very limited knowledge or held inaccurate assumptions about POPs before they started using this method and many stressed the need to disseminate accurate information and resources about POPs to the public.Conclusions: Most focus group discussion participants were satisfied with POPs and supported OTC access. While misconceptions and concerns about POPs should be addressed, an OTC POP has the potential to be a safe, effective, and convenient contraceptive option in the United States.","PeriodicalId":47632,"journal":{"name":"Perspectives on Sexual and Reproductive Health","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perspectives on Sexual and Reproductive Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1363/psrh.12223","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"DEMOGRAPHY","Score":null,"Total":0}

引用次数: 0

Abstract

Context: Removing the prescription requirement and making oral contraceptive pills available over the counter (OTC) could increase contraceptive access in the United States. Despite current efforts to make a progestin-only pill (POP) available OTC, there are no qualitative data exploring the experiences of POP users and their perspectives on making POPs available OTC.

Methods: We conducted six online, asynchronous focus group discussions with 36 POP users between July and November 2020. We stratified focus group discussion placement based on three reasons for POP use: breastfeeding, having a contraindication to estrogen (for a reason other than breastfeeding), and for any other reason. We thematically analyzed these data using inductive and deductive coding.

Results: The majority of participants described their overall POP experience as positive, mostly because they experienced minor or no side effects and thought the pill was effective. Participants overwhelmingly supported OTC availability of POPs and expressed interest in purchasing an OTC POP. Over one-third of participants had very limited knowledge or held inaccurate assumptions about POPs before they started using this method and many stressed the need to disseminate accurate information and resources about POPs to the public.

Conclusions: Most focus group discussion participants were satisfied with POPs and supported OTC access. While misconceptions and concerns about POPs should be addressed, an OTC POP has the potential to be a safe, effective, and convenient contraceptive option in the United States.

查看原文本刊更多论文

美国纯孕激素避孕药使用者的经历以及对非处方药的态度。

背景：在美国，取消处方要求并使口服避孕药在柜台（OTC）销售可增加避孕药具的可及性。尽管目前正在努力使纯孕激素避孕药（POP）在非处方药店销售，但还没有定性数据来探讨 POP 使用者的经历及其对使 POP 在非处方药店销售的看法：我们在 2020 年 7 月至 11 月期间与 36 名 POP 用户进行了六次在线异步焦点小组讨论。我们根据使用持久性有机污染物的三个原因对焦点小组讨论进行了分层：母乳喂养、雌激素禁忌症（除母乳喂养外的其他原因）以及其他原因。我们使用归纳和演绎编码对这些数据进行了专题分析：结果：大多数参与者都认为自己的整体 POP 体验是积极的，这主要是因为她们经历了轻微的副作用或没有副作用，并且认为避孕药是有效的。绝大多数参与者支持在非处方药店购买持久性有机污染物，并表示有兴趣购买非处方药店的持久性有机污染物。超过三分之一的参与者在开始使用这种方法之前对持久性有机污染物的了解非常有限或持有不准确的假设，许多人强调有必要向公众传播有关持久性有机污染物的准确信息和资源：大多数焦点小组讨论参与者对持久性有机污染物表示满意，并支持使用非处方药。虽然应消除对持久性有机污染物的误解和担忧，但在美国，非处方药物持久性有机污染物有可能成为一种安全、有效和方便的避孕选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Perspectives on Sexual and Reproductive Health Multiple-

CiteScore

5.10

自引率

3.40%

发文量

期刊介绍： Perspectives on Sexual and Reproductive Health provides the latest peer-reviewed, policy-relevant research and analysis on sexual and reproductive health and rights in the United States and other developed countries. For more than four decades, Perspectives has offered unique insights into how reproductive health issues relate to one another; how they are affected by policies and programs; and their implications for individuals and societies. Published four times a year, Perspectives on Sexual and Reproductive Health includes original research, special reports and commentaries on the latest developments in the field of sexual and reproductive health, as well as staff-written summaries of recent findings in the field.

文献相关原料

公司名称	产品信息	采购帮参考价格